Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years

Authors :: José Ignacio Chacón
Ruth Alvarez
Ana Royuela
Francisco R García-Arroyo
Cristina Quero Blanco
Juan Ramón Delgado
Luis de la Cruz
Josep Gumá
Marta Llanos
Fernando Franco
Mariano Provencio
José Gómez-Codina
Antonio Rueda
Source :: Leukemia & lymphoma, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Publication Year :: 2018
Publisher :: Informa UK Limited, 2018.
Abstract: Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma (NHL) and represents ∼35% of all NHLs. In the United States there are estimated to be 3.18 cases per 100,000 populations per ...

Full Text Access

Tools